These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epidemiology of benign breast lesions: lack of association with oral contraceptive use. Sartwell PE, Arthes FG, Tonascia JA. N Engl J Med; 1973 Mar 15; 288(11):551-4. PubMed ID: 4685452 [No Abstract] [Full Text] [Related]
3. [Definition of the population groups with high-risk for breast cancer]. van der Linde F. Schweiz Med Wochenschr; 1977 Jul 16; 107(28):962-8. PubMed ID: 897634 [Abstract] [Full Text] [Related]
4. [Oral contraceptives and the prognosis in breast cancer]. Atzinger A. Strahlenther Onkol; 1994 Dec 16; 170(12):722-3. PubMed ID: 7817277 [No Abstract] [Full Text] [Related]
5. [Secondary effects of hormonal contraception on the breast]. Bonte J. Gynakol Rundsch; 1978 Dec 16; 18(3-4):220-45. PubMed ID: 569626 [No Abstract] [Full Text] [Related]
8. [Female sex hormones increase the risk of breast cancer]. Vatten L. Tidsskr Nor Laegeforen; 1998 Aug 20; 118(19):2969-74. PubMed ID: 9748837 [Abstract] [Full Text] [Related]
13. Oral contraception and breast pathology. Ragni N, Boccardo E, Viglino S, Larosa E. Acta Eur Fertil; 1981 Jun 20; 12(2):141-63. PubMed ID: 6794288 [Abstract] [Full Text] [Related]
16. [Oral contraceptives and menopausal estrogens in relation to breast neoplasia]. Brzezinski A, Schenker JG. Harefuah; 1983 Jun 20; 104(11-12):520-3. PubMed ID: 6680711 [No Abstract] [Full Text] [Related]
18. Menstrual factors in relation to breast cancer risk. Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, Stampfer M, Willett W. Cancer Epidemiol Biomarkers Prev; 1998 Sep 20; 7(9):783-9. PubMed ID: 9752986 [Abstract] [Full Text] [Related]